substance p and Asymmetric Diabetic Proximal Motor Neuropathy
substance p has been researched along with Asymmetric Diabetic Proximal Motor Neuropathy in 52 studies
Research
Studies (52)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (13.46) | 18.7374 |
1990's | 26 (50.00) | 18.2507 |
2000's | 8 (15.38) | 29.6817 |
2010's | 9 (17.31) | 24.3611 |
2020's | 2 (3.85) | 2.80 |
Authors
Authors | Studies |
---|---|
Bennett, DLH; Finnerup, NB; Gylfadottir, SS; Itani, M; Jensen, TS; Karlsson, P; Kristensen, AG; Nyengaard, JR; Sindrup, SH; Tankisi, H | 1 |
Issar, T; Krishnan, AV; Kwai, N; Markoulli, M; Pisarcikova, J; Poynten, AM; Tummanapalli, SS; Willcox, MDP; Yan, A | 1 |
Issar, T; Krishnan, AV; Kwai, N; Markoulli, M; Pisarcikova, J; Poynten, AM; Tummanapalli, SS; Willcox, MDP | 1 |
Chen, L; Guo, Z; Li, TP; Liu, CJ; Sun, T; Zhao, X | 1 |
Asano, S; Himeno, T; Inoue, R; Kamiya, H; Kato, K; Kato, M; Kato, Y; Kondo, M; Miura-Yura, E; Mohiuddin, MS; Motegi, M; Nakai-Shimoda, H; Nakamura, J; Naruse, K; Seino, Y; Suzuki, A; Tsunekawa, S; Yamada, Y | 1 |
Altdorfer, K; Batbayar, B; Fehér, E; Hevér, H; Zelles, T | 1 |
Cheng, HT; Dauch, JR; Feldman, EL; Hsieh, W; Porzio, MT; Singleton, JR; Smith, AG; Yanik, BM | 1 |
Auster, ME; Carvalho, E; Kafanas, A; Kearney, C; Kokkotou, E; Kuchibhotla, S; Leal, EC; LoGerfo, FW; Mooney, DJ; Pradhan-Nabzdyk, L; Tecilazich, F; Tellechea, A; Veves, A | 1 |
Albiero, M; Avogaro, A; Canal, F; Cappellari, R; Carnelli, F; Dang, Z; Emanueli, C; Fadini, GP; Falco, A; Furlan, A; Lorusso, B; Madeddu, P; Maselli, D; Ou, K; Paccagnella, A; Paiola, E; Quaini, F; Rodriguez-Arabaolaza, I; Rosa, F; Sambataro, M; Sangalli, E; Seganfreddo, E; Specchia, C; Spinetti, G | 1 |
Chen, CH; Hong, YR; Howng, SL; Hsu, KS; Huang, HT; Lai, CL; Lam, HC; Liu, GS; Shi, JY; Shin, SJ; Tai, MH; Wen, ZH | 1 |
Bosch, F; De Giorgio, R; Domènech, A; Gori, A; Jiménez, M; Pasquinelli, G; Pumarola, M | 1 |
Kovács, P; Németh, J; Paragh, G; Peitl, B; Sári, R; Szilvássy, Z; Vígh, L | 1 |
Ansel, JC; Bunnett, N; Gibran, NS; Greenhalgh, DG; Isik, FF; Jang, YC; Larsen, J; Muffley, LA; Olerud, JE; Smith, DG; Underwood, RA; Usui, ML | 1 |
Kakinoki, B; Ohgami, T; Saito, K; Sejima, M; Sekimoto, S; Yamagami, K; Yuki, S | 1 |
Calcutt, NA; Freshwater, JD; Hauptmann, N; Mizisin, AP; Taylor, EM | 1 |
Kamiya, H; Sima, AA; Zhang, W | 1 |
Ekberg, K; Kamiya, H; Sima, AA; Wahren, J; Zhang, W | 1 |
Dhanasekaran, S; Mensah-Brown, E; Morrison, JF; Shaffiullah, M; Sheen, R; Shehab, S | 1 |
Emson, PC; Hosobuchi, Y; Iversen, LL | 1 |
Apfel, SC; Arezzo, JC; Brownlee, M; Federoff, H; Kessler, JA | 1 |
Hikawa, N; Horie, H; Inoue, S; Sango, K; Sotelo, JR; Takenaka, T; Tanaka, S; Verdes, JM | 1 |
Carrington, AL; Chen, S; Polak, JM; Terenghi, G; Tomlinson, DR | 1 |
Bartke, I; Reiter, R; Schmidt, Y; Unger, JW | 1 |
Echtenkamp, SF; Marfurt, CF | 1 |
Di Giulio, AM; Gorio, A; Lesma, E | 1 |
Badendick, K; Håkanson, R; Sundler, F; Wallengren, J; Zander, E | 1 |
Borella, F; Di Giulio, AM; Donadoni, ML; Gavezzotti, R; Gorio, A | 1 |
Abraham, RR; Berg, TJ; Levy, DM; Reid, G | 1 |
Ohkubo, Y; Takeshita, N; Yamaguchi, I | 1 |
Diemel, LT; Tomlinson, DR; Tsigos, C; White, A; Young, RJ | 1 |
Belai, A; Burnstock, G; Soediono, P | 1 |
Courteix, C; Eschalier, A; Lavarenne, J | 1 |
Anand, P; Kopelman, P; Sinicropi, DV; Terenghi, G; Warner, G; Williams-Chestnut, RE | 1 |
Belai, A; Burnstock, G | 1 |
Borella, F; Di Giulio, AM; Donadoni, ML; Finco, C; Gorio, A | 1 |
Cruwys, SC; Garrett, NE; Kidd, BL; Tomlinson, DR | 1 |
Diemel, LT; Fernyhough, P; Tomlinson, DR | 1 |
Boden, P; Field, MJ; Hughes, J; McCleary, S; Singh, L; Suman-Chauhan, N | 1 |
Corder, R; Horrobin, DF; Hounsom, L; Tomlinson, DR; Tritschler, H | 1 |
Klitzsch, T; Pera, S; Reiter, R; Unger, JW | 1 |
Corder, R; Hounsom, L; Patel, J; Tomlinson, DR | 1 |
Bertelli, A; Di Giulio, AM; Donadoni, L; Germani, E; Gorio, A; Mantegazza, P; Tenconi, B | 1 |
Bertelli, A; Di Giulio, AM; Donadoni, L; Germani, E; Gorio, A; Maccari, F; Mantegazza, P; Ramacci, MT; Tenconi, B | 1 |
Bertelli, A; Di Giulio, AM; Ferraris, L; Gorio, A; Mantegazza, P; Ramacci, MT | 1 |
Francavilla, S; Karanth, SS; Mirrlees, DJ; Polak, JM; Springall, DR | 1 |
Diemel, LT; Leach, RM; Smith, WJ; Tomlinson, DR | 1 |
MacLean, DB | 1 |
Aronin, N; Clements, RS; Leeman, SE | 1 |
Burnstock, G; Crowe, R | 1 |
Karanth, SS; Levy, DM; Polak, JM; Springall, DR | 1 |
Kristensson, K; Lindberger, M; Link, H; Ostman, J; Persson, A; Schröder, HD; Schultzberg, M | 1 |
Abbracchio, MP; Cattabeni, F; Di Giulio, AM; Gorio, A; La Croix, R; Mantegazza, P; Tenconi, B | 1 |
Other Studies
52 other study(ies) available for substance p and Asymmetric Diabetic Proximal Motor Neuropathy
Article | Year |
---|---|
Analysis of Macrophages and Peptidergic Fibers in the Skin of Patients With Painful Diabetic Polyneuropathy.
Topics: Aged; Biomarkers; Biopsy; Calcitonin Gene-Related Peptide; Cross-Sectional Studies; Diabetic Neuropathies; Female; Humans; Macrophages; Male; Middle Aged; Nerve Fibers; Neuralgia; Skin; Substance P | 2022 |
Tear film substance P: A potential biomarker for diabetic peripheral neuropathy.
Topics: Adult; Biomarkers; Cross-Sectional Studies; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Prospective Studies; Substance P; Tears | 2019 |
A Comparative Study on the Diagnostic Utility of Corneal Confocal Microscopy and Tear Neuromediator Levels in Diabetic Peripheral Neuropathy.
Topics: Adult; Area Under Curve; Calcitonin Gene-Related Peptide; Cornea; Corneal Diseases; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Microscopy, Confocal; Middle Aged; Prospective Studies; ROC Curve; Substance P; Tears; Trigeminal Nerve Diseases | 2020 |
Association of down-regulation of calcitonin gene-related peptide and substance P with increase of myocardial vulnerability in diabetic neuropathic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rats; Substance P | 2017 |
Glucagon-Like Peptide-1 Receptor Agonist Protects Dorsal Root Ganglion Neurons against Oxidative Insult.
Topics: Animals; Antioxidants; Apoptosis; Calcitonin; Cell Line; Cell Proliferation; Cell Survival; Cyclic AMP; Diabetic Neuropathies; Ganglia, Spinal; Glucagon-Like Peptide-1 Receptor; Hypoglycemic Agents; Neurons; Neuroprotective Agents; Oxidative Stress; Rats; Substance P; Superoxide Dismutase | 2019 |
[Changes in the innervation of the taste buds in diabetic rats].
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Galanin; Hypoglycemic Agents; Immunohistochemistry; Insulin; Lymphocyte Count; Male; Mast Cells; Nerve Endings; Neuropeptide Y; Rats; Rats, Inbred Strains; Streptozocin; Substance P; Taste Buds; Time Factors; Vasoactive Intestinal Peptide | 2013 |
Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy.
Topics: Aged; Axons; Diabetic Neuropathies; Epidermis; Female; GAP-43 Protein; Humans; Male; Middle Aged; Nerve Degeneration; Nerve Fibers; Neuralgia; Pain Measurement; Receptor, trkA; Substance P; TRPV Cation Channels | 2013 |
Substance P promotes wound healing in diabetes by modulating inflammation and macrophage phenotype.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Inflammation; Macrophages; Mice; Rabbits; Receptors, Neurokinin-1; Skin; Substance P; Wound Healing | 2015 |
Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes.
Topics: Animals; Cross-Sectional Studies; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Hematopoietic Stem Cells; Humans; Mice; Nociception; Sensory Receptor Cells; Substance P | 2015 |
Peripheral gene transfer of glial cell-derived neurotrophic factor ameliorates neuropathic deficits in diabetic rats.
Topics: Animals; Axons; Calcitonin Gene-Related Peptide; Diabetic Neuropathies; Gene Transfer Techniques; Genetic Therapy; Glial Cell Line-Derived Neurotrophic Factor; Hyperglycemia; Injections, Intramuscular; Myelin Sheath; Rats; Sciatic Nerve; Signal Transduction; Streptozocin; Substance P | 2009 |
Morphofunctional changes underlying intestinal dysmotility in diabetic RIP-I/hIFNβ transgenic mice.
Topics: Animals; Choline O-Acetyltransferase; Colon; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Disease Models, Animal; Gastric Emptying; Gastrointestinal Motility; Ileum; Interferon-beta; Male; Mice; Mice, Transgenic; Myenteric Plexus; Nitric Oxide Synthase Type I; Receptor-Interacting Protein Serine-Threonine Kinases; Streptozocin; Substance P; Vasoactive Intestinal Peptide | 2011 |
Insulin resistance occurs in parallel with sensory neuropathy in streptozotocin-induced diabetes in rats: differential response to early vs late insulin supplementation.
Topics: Animals; Blood Glucose; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucose Clamp Technique; Insulin; Insulin Resistance; Male; Neural Conduction; Rats; Rats, Wistar; Sensory Receptor Cells; Somatostatin; Substance P | 2012 |
Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus.
Topics: Aged; Animals; Diabetic Neuropathies; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Middle Aged; Nerve Endings; Skin; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Wound Healing | 2002 |
Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Male; Nerve Growth Factor; Neural Conduction; Neuroprotective Agents; PC12 Cells; Peripheral Nervous System Diseases; Phosphorylation; Rats; Rats, Wistar; Receptor, trkA; Sialic Acids; Skin; Streptozocin; Substance P; Ubiquitin Thiolesterase | 2006 |
Protection of sensory function in diabetic rats by Neotrofin.
Topics: Aminobenzoates; Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Hypoxanthines; Nerve Growth Factor; Neural Conduction; Neurons, Afferent; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Skin; Spinal Nerve Roots; Streptozocin; Substance P; Time Factors | 2006 |
Degeneration of the Golgi and neuronal loss in dorsal root ganglia in diabetic BioBreeding/Worcester rats.
Topics: Animals; Axons; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ganglia, Spinal; Golgi Apparatus; Hindlimb; Hot Temperature; Nerve Growth Factors; Neurons; Prediabetic State; Rats; Rats, Inbred BB; Receptor, IGF Type 1; Receptor, Insulin; Sciatic Nerve; Substance P | 2006 |
C-Peptide reverses nociceptive neuropathy in type 1 diabetes.
Topics: Animals; C-Peptide; Calcitonin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ganglia, Spinal; Male; Nerve Fibers; Nerve Regeneration; Neuritis; Neurons; Rats; Rats, Inbred BB; Reference Values; Substance P | 2006 |
Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes.
Topics: Aging; Animals; Autonomic Nervous System; Blood Glucose; Body Weight; Calcitonin Gene-Related Peptide; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Glucose Intolerance; Glucose Tolerance Test; Hot Temperature; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Neurons, Afferent; Obesity; Organ Size; Pain Measurement; Physical Stimulation; Radioimmunoassay; Rats; Rats, Wistar; Receptors, Neurokinin-1; Sodium Glutamate; Substance P | 2008 |
Elevated cerebrospinal fluid substance P in arachnoiditis is reduced by systemic administration of morphine.
Topics: Arachnoiditis; Diabetic Neuropathies; Humans; Morphine; Pain; Substance P | 1982 |
Nerve growth factor administration protects against experimental diabetic sensory neuropathy.
Topics: Action Potentials; Animals; Behavior, Animal; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Nerve Growth Factors; Rats; Rats, Wistar; Substance P | 1994 |
Nerve growth factor (NGF) restores depletions of calcitonin gene-related peptide and substance P in sensory neurons from diabetic mice in vitro.
Topics: Animals; Calcitonin Gene-Related Peptide; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Ganglia, Spinal; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Nerve Growth Factors; Nerve Tissue Proteins; Neurons, Afferent; Streptozocin; Substance P | 1994 |
Changes in sensory neuropeptides in dorsal root ganglion and spinal cord of spontaneously diabetic BB rats. A quantitative immunohistochemical study.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetic Neuropathies; Ganglia, Spinal; Neurons, Afferent; Neuropeptides; Peripheral Nervous System Diseases; Rats; Rats, Inbred BB; Spinal Cord; Substance P | 1994 |
Effect of nerve growth factor on peptide neurons in dorsal root ganglia after taxol or cisplatin treatment and in diabetic (db/db) mice.
Topics: Animals; Calcitonin Gene-Related Peptide; Cisplatin; Diabetic Neuropathies; Ganglia, Spinal; Mice; Nerve Growth Factors; Paclitaxel; Substance P | 1995 |
The effect of diabetes on neuropeptide content in the rat cornea and iris.
Topics: Animals; Calcitonin Gene-Related Peptide; Cornea; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Immunoenzyme Techniques; Iris; Neurons; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Substance P; Vasoactive Intestinal Peptide | 1995 |
Diabetic neuropathy in the rat: 1. Alcar augments the reduced levels and axoplasmic transport of substance P.
Topics: Alloxan; Animals; Axons; Blood Glucose; Body Weight; Carnitine; Diabetic Neuropathies; Male; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Substance P | 1995 |
Innervation of the skin of the forearm in diabetic patients: relation to nerve function.
Topics: Adult; Aged; Autonomic Nervous System; Axons; Calcitonin Gene-Related Peptide; Case-Control Studies; Diabetes Mellitus; Diabetic Neuropathies; Female; Forearm; Humans; Male; Middle Aged; Nerve Fibers; Neurons, Afferent; Neuropeptide Y; Parasympathetic Nervous System; Skin; Substance P; Sympathetic Nervous System; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1995 |
Experimental diabetic neuropathy. Inhibition of protein mono-ADP-ribosylation prevents reduction of substance P axonal transport.
Topics: Adenosine Diphosphate Ribose; Animals; Axons; Biological Transport; Blood Glucose; Body Weight; Diabetic Neuropathies; Male; Rats; Rats, Sprague-Dawley; Retina; Substance P | 1995 |
The effects of vasoactive intestinal polypeptide and substance P on methacholine-induced sweating and vascular flare in diabetic neuropathy.
Topics: Adult; Blood Vessels; Diabetic Neuropathies; Humans; Male; Methacholine Chloride; Middle Aged; Peripheral Nervous System Diseases; Substance P; Sweating; Vasoactive Intestinal Peptide | 1995 |
Tiapride attenuates pain transmission through an indirect activation of central serotonergic mechanism.
Topics: Animals; Central Nervous System; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dopamine Antagonists; Female; Fenclonine; Indoles; Injections, Spinal; Ketanserin; Male; Mice; Nociceptors; Pain; Pain Measurement; Pindolol; Serotonin; Serotonin Antagonists; Somatostatin; Substance P; Synaptic Transmission; Tiapamil Hydrochloride; Tropisetron | 1995 |
Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy.
Topics: Calcitonin Gene-Related Peptide; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Pain; Substance P; Sural Nerve | 1993 |
Prevention of neuropathy in the pyloric sphincter of streptozotocin-diabetic rats by gangliosides.
Topics: Animals; Biomarkers; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enkephalin, Methionine; Fluorescent Antibody Technique; Gangliosides; Male; Neurons; Neuropeptide Y; Pylorus; Rats; Rats, Wistar; Substance P; Thiolester Hydrolases; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1993 |
RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats.
Topics: Analgesics; Analysis of Variance; Animals; Diabetic Neuropathies; Hyperalgesia; Indoles; Isoindoles; Male; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Stereoisomerism; Substance P | 1993 |
The role of endogenous nerve growth factor in human diabetic neuropathy.
Topics: Adolescent; Adult; Axons; Diabetic Neuropathies; Female; Foot; Humans; Male; Nerve Growth Factors; Reflex; Sensation; Skin; Substance P | 1996 |
Acrylamide-induced neuropathic changes in rat enteric nerves: similarities with effects of streptozotocin-diabetes.
Topics: Acrylamide; Acrylamides; Animals; Autonomic Pathways; Calcitonin Gene-Related Peptide; Catecholamines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Intestines; Male; Nerve Fibers; Neuropeptide Y; Norepinephrine; Rats; Rats, Wistar; Substance P; Vasoactive Intestinal Peptide | 1996 |
Alterations of protein mono-ADP-ribosylation and diabetic neuropathy: a novel pharmacological approach.
Topics: Adenosine Diphosphate Ribose; Animals; Autoradiography; Blood Glucose; Body Weight; Diabetic Neuropathies; Ganglia, Spinal; Ganglia, Sympathetic; Male; Nerve Tissue Proteins; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Subcellular Fractions; Substance P | 1996 |
Effect of streptozotocin-diabetes on knee joint inflammation-induced changes in substance P and nerve growth factor in the rat.
Topics: Animals; Diabetic Neuropathies; Inflammation; Joints; Knee; Male; Nerve Growth Factors; Rats; Rats, Wistar; Streptozocin; Substance P | 1996 |
Role of neurotrophins in diabetic neuropathy and treatment with nerve growth factors.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Insulin; Motor Neurons; Nerve Growth Factors; Nerve Regeneration; Neural Conduction; Neurons, Afferent; Neurotrophin 3; Rats; Receptor, trkA; RNA, Messenger; Sciatic Nerve; Substance P | 1997 |
Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat.
Topics: Animals; Benzofurans; Carbamates; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Electrophysiology; Gerbillinae; Glycine; Guinea Pigs; Humans; Male; Neurokinin-1 Receptor Antagonists; Pain; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Substance P | 1998 |
A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.
Topics: Animals; Antioxidants; Butylated Hydroxytoluene; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Linolenic Acid; Male; Motor Neurons; Nerve Growth Factors; Neural Conduction; Neurons, Afferent; Neuropeptide Y; Rats; Rats, Wistar; Sciatic Nerve; Substance P; Thioctic Acid | 1998 |
Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations of the sural nerve, dorsal root ganglion, and spinal cord.
Topics: Animals; Blood Glucose; Calcitonin Gene-Related Peptide; Cell Size; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Glycated Hemoglobin; Immunohistochemistry; Male; Myelin Sheath; Nerve Fibers; Nerve Growth Factors; Neuropeptides; Proto-Oncogene Proteins; Radioimmunoassay; Rats; Rats, Inbred Lew; Receptor Protein-Tyrosine Kinases; Receptor, trkA; Receptors, Nerve Growth Factor; Spinal Cord; Substance P; Sural Nerve | 1998 |
Oxidative stress participates in the breakdown of neuronal phenotype in experimental diabetic neuropathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; gamma-Linolenic Acid; Male; Nerve Growth Factor; Neural Conduction; Neurons; Neuropeptide Y; Oxidative Stress; Phenotype; Primaquine; Rats; Rats, Wistar; Sciatic Nerve; Substance P; Thioctic Acid; Vitamin E | 2001 |
Early neurochemical changes in the autonomic neuropathy of the gut in experimental diabetes.
Topics: Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; GTP-Binding Proteins; Intestinal Mucosa; Intestines; Male; Neuropeptides; Rats; Rats, Sprague-Dawley; Serotonin; Signal Transduction; Substance P; Vasoactive Intestinal Peptide | 1992 |
Peptide alterations in autonomic diabetic neuropathy prevented by acetyl-L-carnitine.
Topics: Acetylcarnitine; Animals; Autonomic Nervous System Diseases; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enkephalin, Methionine; Intestinal Mucosa; Intestines; Male; Neuropeptides; Rats; Rats, Sprague-Dawley; Substance P; Vasoactive Intestinal Peptide | 1992 |
Acetyl-L-carnitine prevents substance P loss in the sciatic nerve and lumbar spinal cord of diabetic animals.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Lumbar Vertebrae; Male; Rats; Rats, Sprague-Dawley; Sciatic Nerve; Spinal Cord; Substance P | 1992 |
Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fluorescent Antibody Technique; Male; Nerve Fibers; Neuropeptide Y; Neuropeptides; Rats; Rats, Inbred Strains; Skin; Substance P; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1990 |
Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: evidence for a partial role of endoneurial hypoxia in diabetic neuropathy.
Topics: Animals; Diabetic Neuropathies; Glucose; Hypoxia; Inositol; Male; Nerve Tissue Proteins; Neural Conduction; Peripheral Nervous System Diseases; Rats; Rats, Inbred Strains; Sciatic Nerve; Skin; Sodium-Potassium-Exchanging ATPase; Substance P | 1991 |
Substance P and somatostatin content and transport in vagus and sciatic nerves of the streptozocin-induced diabetic rat.
Topics: Animals; Axonal Transport; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Rats; Rats, Inbred Strains; Sciatic Nerve; Somatostatin; Substance P; Vagus Nerve | 1987 |
Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin.
Topics: Capsaicin; Diabetic Neuropathies; Female; Histamine; Humans; Male; Middle Aged; Nerve Fibers; Peripheral Nerves; Skin Tests; Substance P | 1987 |
An increase of vasoactive intestinal polypeptide-, but not neuropeptide Y-, substance P- or catecholamine-containing nerves in the iris of the streptozotocin-induced diabetic rat.
Topics: Adrenergic Fibers; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Iris; Male; Nerve Fibers; Neuropeptide Y; Rats; Rats, Inbred Strains; Substance P; Vasoactive Intestinal Peptide | 1988 |
Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study.
Topics: Adult; Aged; Biopsy; Calcitonin Gene-Related Peptide; Diabetes Mellitus; Diabetic Neuropathies; Female; Humans; Immunohistochemistry; Male; Middle Aged; Neuropeptide Y; Neuropeptides; Skin; Substance P; Ubiquitin Thiolesterase; Vasoactive Intestinal Peptide | 1989 |
Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus.
Topics: Adult; Calcitonin Gene-Related Peptide; Diabetic Neuropathies; Humans; Immunohistochemistry; Middle Aged; Substance P | 1989 |
Denervation and hyperinnervation in the nervous system of diabetic animals. II. Monoaminergic and peptidergic alterations in the diabetic encephalopathy.
Topics: Animals; Biogenic Monoamines; Brain; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enkephalin, Methionine; Male; Neuropeptides; Rats; Rats, Inbred Strains; Substance P; Vasoactive Intestinal Peptide | 1989 |